The association between insulin-like growth factor I and bone turnover markers in the general adult population

Bone

Volumn 56, Issue 1, 2013, Pages 184-190

  Niemann, Inga ^a   Hannemann, Anke ^a   Nauck, Matthias ^a   Spielhagen, Christin ^a   Völzke, Henry ^a   Wallaschofski, Henri ^a   Friedrich, Nele ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

BAP; Bone turnover markers; CTX; Insulin like growth factor I; PINP; Study of Health in Pomerania

Indexed keywords

ALKALINE PHOSPHATASE; BONE SPECIFIC ALKALINE PHOSPHATASE; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN; PROTEIN PINP; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; BONE TURNOVER; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; OSSIFICATION; OSTEOLYSIS; PREMENOPAUSE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; UPREGULATION;

BAP; BONE TURNOVER MARKERS; CTX; INSULIN-LIKE GROWTH FACTOR I; PINP; STUDY OF HEALTH IN POMERANIA;

ADULT; AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE REMODELING; COLLAGEN TYPE I; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN; YOUNG ADULT;

EID: 84880148878     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.06.013     Document Type: Article

References (55)

1. Bikle D.D. Insulin-like growth factor-I and bone. IBMS BoneKEy 2001, 8.
2. Giustina A., Mazziotti G., Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 2008, 29:535-559.
3. Mochizuki H., Hakeda Y., Wakatsuki N., Usui N., Akashi S., Sato T., et al. Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology 1992, 131:1075-1080.
4. Ueland T. GH/IGF-I and bone resorption in vivo and in vitro. Eur J Endocrinol 2005, 152:327-332.
5. Ueland T. Bone metabolism in relation to alterations in systemic growth hormone. Growth Horm IGF Res 2004, 14:404-417.
6. Jones J.I., Gockerman A., Busby W.H., Camacho-Hubner C., Clemmons D.R. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 1993, 121:679-687.
7. Mohan S., Baylink D.J. Insulin-like growth factor system components and the coupling of bone formation to resorption. Horm Res 1996, 45(Suppl. 1):59-62.
8. Barrett-Connor E., Goodman-Gruen D. Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo Study. J Bone Miner Res 1998, 13:1343-1349.
9. Boonen S., Lesaffre E., Dequeker J., Aerssens J., Nijs J., Pelemans W., et al. Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70years: potential implications for the prevention of age-related bone loss. J Am Geriatr Soc 1996, 44:1301-1306.
10. Gillberg P., Olofsson H., Mallmin H., Blum W.F., Ljunghall S., Nilsson A.G. Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif Tissue Int 2002, 70:22-29.
11. Langlois J.A., Rosen C.J., Visser M., Hannan M.T., Harris T., Wilson P.W., et al. Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 1998, 83:4257-4262.
12. Szulc P., Joly-Pharaboz M.O., Marchand F., Delmas P.D. Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60years of age: MINOS study. Calcif Tissue Int 2004, 74:322-329.
13. Vestergaard P., Hermann A.P., Orskov H., Mosekilde L. Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study. J Clin Endocrinol Metab 1999, 84:2286-2290.
14. Bianda T., Glatz Y., Bouillon R., Froesch E.R., Schmid C. Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults. J Clin Endocrinol Metab 1998, 83:81-87.
15. Johansson A.G., Lindh E., Blum W.F., Kollerup G., Sorensen O.H., Ljunghall S. Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 1996, 81:44-48.
16. Kann P., Piepkorn B., Schehler B., Andreas J., Lotz J., Prellwitz W., et al. Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clin Endocrinol (Oxf) 1998, 48:561-568.
17. Sneppen S.B., Hoeck H.C., Kollerup G., Sorensen O.H., Laurberg P., Feldt-Rasmussen U. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults-an 18-month randomised, placebo-controlled, double blinded trial. Eur J Endocrinol 2002, 146:187-195.
18. White H.D., Ahmad A.M., Syed A.A., Clewes A., Peter R., Vora J.P., et al. Gender variation in PTH sensitivity and rhythmicity following growth hormone replacement in adult growth hormone-deficient patients. Clin Endocrinol (Oxf) 2004, 60:516-526.
19. Ebeling P.R., Jones J.D., O'Fallon W.M., Janes C.H., Riggs B.L. Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 1993, 77:1384-1387.
20. Bolanowski M., Daroszewski J., Medras M., Zadrozna-Sliwka B. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. J Bone Miner Metab 2006, 24:72-78.
21. Parkinson C., Kassem M., Heickendorff L., Flyvbjerg A., Trainer P.J. Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal. J Clin Endocrinol Metab 2003, 88:5650-5655.
22. Sucunza N., Barahona M.J., Resmini E., Fernandez-Real J.M., Ricart W., Farrerons J., et al. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly. J Clin Endocrinol Metab 2009, 94:3889-3896.
23. Adami S., Zivelonghi A., Braga V., Fracassi E., Gatti D., Rossini M., et al. Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. Bone 2010, 46:244-247.
24. Collins D., Woods A., Herd R., Blake G., Fogelman I., Wheeler M., et al. Insulin-like growth factor-I and bone mineral density. Bone 1998, 23:13-16.
25. Fatayerji D., Eastell R. Age-related changes in bone turnover in men. J Bone Miner Res 1999, 14:1203-1210.
26. Gurlek A., Gedik O. Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover. J Endocrinol Invest 2001, 24:408-414.
27. Kim J.G., Shin C.S., Choi Y.M., Moon S.Y., Kim S.Y., Lee J.Y. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60. Clin Endocrinol (Oxf) 1999, 51:301-307.
28. Nabipour I., Larijani B., Beigi S., Jafari S.M., Amiri M., Assadi M., et al. Relationship among insulinlike growth factor I concentrations, bone mineral density, and biochemical markers of bone turnover in postmenopausal women: a population-based study. Menopause 2008, 15:934-939.
29. Rucker D., Ezzat S., Diamandi A., Khosravi J., Hanley D.A. IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men. Clin Endocrinol (Oxf) 2004, 60:491-499.
30. Sezgin M. Serum IGF-I and IGFBP-3 levels in middle aged Turkish males: relationship with bone mineral density and markers of bone turnover. Osteoporoz Dünyasindan 2007, 13:37-43.
31. Walsh J.S., Henry Y.M., Fatayerji D., Eastell R. Hormonal determinants of bone turnover before and after attainment of peak bone mass. Clin Endocrinol (Oxf) 2010, 72:320-327.
32. Collett-Solberg P.F., Cohen P. Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine 2000, 12:121-136.
33. Rajaram S., Baylink D.J., Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 1997, 18:801-831.
34. Adami S., Bianchi G., Brandi M.L., Giannini S., Ortolani S., DiMunno O., et al. Determinants of bone turnover markers in healthy premenopausal women. Calcif Tissue Int 2008, 82:341-347.
35. Ebeling P.R., Atley L.M., Guthrie J.R., Burger H.G., Dennerstein L., Hopper J.L., et al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 1996, 81:3366-3371.
36. Szulc P., Garnero P., Munoz F., Marchand F., Delmas P.D. Cross-sectional evaluation of bone metabolism in men. J Bone Miner Res 2001, 16:1642-1650.
37. Volzke H., Alte D., Schmidt C.O., Radke D., Lorbeer R., Friedrich N., et al. Cohort profile: the Study of Health in Pomerania. Int J Epidemiol 2011, 40:294-307.
38. Levey A.S., Greene T., Kusek J.W., Beck G.L. MDRD study group, a simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 2000, 11:155A.
39. Koenker R. Quantile regression, econometric society monograph series 2005, Cambridge University Press, New York.
40. Stone C., Koo C.Y. Additive splines in statistics. Proceedings of the statistical computing section 1985, American Statistcal Association, Washington, DC.
41. Frystyk J. Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 2004, 14:337-375.
42. Christenson R.H. Biochemical markers of bone metabolism: an overview. Clin Biochem 1997, 30:573-593.
43. Ekman B., Nystrom F., Arnqvist H.J. Circulating IGF-I concentrations are low and not correlated to glycaemic control in adults with type 1 diabetes. Eur J Endocrinol 2000, 143:505-510.
44. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 2003, 13:113-170.
45. Teppala S., Shankar A. Association between serum IGF-1 and diabetes among U.S. adults. Diabetes Care 2010, 33:2257-2259.
46. Clemmons D.R. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem 2011, 57:555-559.
47. Vasikaran S., Eastell R., Bruyere O., Foldes A.J., Garnero P., Griesmacher A., et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 2011, 22:391-420.
48. Ueland T., Odgren P.R., Yndestad A., Godang K., Schreiner T., Marks S.C., et al. Growth hormone substitution increases gene expression of members of the IGF family in cortical bone from women with adult onset growth hormone deficiency-relationship with bone turn-over. Bone 2003, 33:638-645.
49. van der Klaauw A.A., Bax J.J., Roelfsema F., Stokkel M.P., Bleeker G.B., Biermasz N.R., et al. Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly. Pituitary 2009, 12:339-346.
50. Brabant G., von zur Muhlen A., Wuster C., Ranke M.B., Kratzsch J., Kiess W., et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res 2003, 60:53-60.
51. Friedrich N., Alte D., Volzke H., Spilcke-Liss E., Ludemann J., Lerch M.M., et al. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP). Growth Horm IGF Res 2008, 18:228-237.
52. Jernstrom H., Deal C., Wilkin F., Chu W., Tao Y., Majeed N., et al. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 2001, 10:377-384.
53. Chenu C., Valentin-Opran A., Chavassieux P., Saez S., Meunier P.J., Delmas P.D. Insulin like growth factor I hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term cultures. Bone 1990, 11:81-86.
54. Okazaki R., Conover C.A., Harris S.A., Spelsberg T.C., Riggs B.L. Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not. J Bone Miner Res 1995, 10:788-795.
55. Yakar S., Liu J.L., Stannard B., Butler A., Accili D., Sauer B., et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A 1999, 96:7324-7329.